Exploring cell dynamics and tumor microenvironments: a comprehensive review of decellularized extracellular matrix (dECM) scaffolds in breast and prostate cancer research

Sho’leh Ghaedamini , Forouzan Rahmani, Zahra Sadeghi, Maryam Anjomshoa, Ali Honarvar

Abstract


Background and Purpose: Decellularized extracellular matrix (dECM) scaffolds offer advanced platforms for studying breast and prostate cancer, enabling the replication of the tumor microenvironment (TME) with high fidelity. This review summarizes methodologies for creating dECM scaffolds, highlighting their biochemical and mechanical properties that enable up to 70% greater physiological relevance compared to traditional               two-dimensional cultures.

Search Strategy: A systematic literature search was conducted on PubMed, Scopus, and Web of Science databases (2010-2025) using keywords such as "decellularized extracellular matrix," "breast cancer," "prostate cancer," and "tumor microenvironment." Inclusion criteria focused on peer-reviewed studies employing dECM scaffolds in breast and prostate cancer research.

Findings: Key findings reveal that dECM scaffolds effectively mimic tissue-specific TMEs, facilitating the study of tumor-stroma interactions, cellular responses, and drug resistance in breast and prostate cancers. dECM supports enhanced understanding of cancer progression mechanisms, including increased invasiveness, chemoresistance, and cell proliferation. Differences in decellularization methods influence ECM composition and scaffold function. Challenges, including standardization, clinical validation, and scalability, remain.

Conclusion and Future Trends: dECM scaffolds hold great potential to advance cancer biology research and precision therapy development by providing biomimetic platforms. Future directions include integrating bioengineering advancements, AI-assisted ECM analysis, organoid and organ-on-chip models, and enhanced decellularization protocols to improve model fidelity and clinical relevance.

 

 


Keywords


Breast cancer; Decellularization; Extracellular matrix; Prostate cancer; Scaffold.

Full Text:

PDF

References


Shoari A, Khodabakhsh F, Ahangari Cohan R, Salimian M, Karami E. Anti-angiogenic peptides application in cancer therapy;a review. Res Pharm Sci. 2021;16(6):559-574.DOI: 10.4103/1735-5362.327503.

Costard LS, Hosn RR, Ramanayake H, O'Brien FJ, Curtin CM. Influences of the 3D microenvironment on cancer cell behaviour and treatment responsiveness: a recent update on lung, breast and prostate cancer models. Acta Biomater. 2021;132:360-378.DOI: 10.1016/j.actbio.2021.01.023.

Ghaedamini Sl, Hashemibeni B, Honarvar A, Rabiei A, Karbasi S. Recent innovations in strategies for breast cancer therapy by electrospun scaffolds:a review. J Polym Environ. 2023;32(3):1-27.DOI: 10.1007/s10924-023-03022-6.

Ghaedamini Sl, Kazemi M, Rabiei A, Honarvar A, Aliakbari M, Karbasi S. Anti-tumor effects of ellagic acid and mesenchymal stem cell-conditioned medium on breast cancer cells on the 3D printed PCL/agarose scaffolds. J Drug Deliv Sci Tech. 2024;101(10):106315.DOI: 10.1016/j.jddst.2024.106315.

Hoshiba T. Decellularized extracellular matrix for cancer research. Materials. 2019;12(8):1311,1-16.DOI: 10.3390/ma12081311.

Negishi J, Yamaguchi A, Tanaka D, Hashimoto Y, Zhang Y, Funamoto S. A method for fabricating tissue-specific extracellular matrix blocks from decellularized tissue powders. Adv Biol (Weinh). 2025;9(1):e2400398.DOI: 10.1002/adbi.202400398.

Gholami K, Izadi M, Heshmat R, Aghamir SMK. Exploring the potential of solid and liquid amniotic membrane biomaterial in 3D models for prostate cancer research:a comparative analysis with 2D models. Tissue Cell. 2025;93:102726.DOI: 10.1016/j.tice.2025.102726.

Zhang L, Zhou J, Kong W. Extracellular matrix in vascular homeostasis and disease. Nat Rev Cardiol. 2025;22(5):333-353.DOI: 10.1038/s41569-024-01103-0.

Ferreira LP, Gaspar VM, Mano JF. Decellularized extracellular matrix for bioengineering physiomimetic 3d in vitro tumor models. Trends Biotechnol. 2020;38(12):1397-1414.DOI: 10.1016/j.tibtech.2020.04.006.

Pierantoni L, Silva-Correia J, Motta A, Reis RL, Oliveira JM. Biomaterials as ECM-like matrices for 3D in vitro tumor models. Biomaterials for 3D Tumor Modeling. Elsevier. 2020;157-173.DOI: 10.1016/B978-0-12-818128-7.00007-1.

Bonnans C, Chou J, Werb Z. Remodelling the extracellular matrix in development and disease. Nat Rev Mol Cell Biol. 2014;15(12):786-801.DOI: 10.1038/nrm3904.

Yao Q, Zheng YW, Lan QH, Kou L, Xu HL, Zhao YZ. Recent development and biomedical applications of decellularized extracellular matrix biomaterials. Mater Sci Eng C Mater Biol Appl. 2019;104:109942,1-10.DOI: 10.1016/j.msec.2019.109942.

Tian X, Werner ME, Roche KC, Hanson AD, Foote HP, Yu SK, et al. Organ-specific metastases obtained by culturing colorectal cancer cells on tissue-specific decellularized scaffolds. Nat Biomed Eng. 2018;2(6):443-452.DOI: 10.1038/s41551-018-0231-0.

Alabi BR, LaRanger R, Shay JW. Decellularized mice colons as models to study the contribution of the extracellular matrix to cell behavior and colon cancer progression. Acta Biomater. 2019;100:213-222.DOI: 10.1016/j.actbio.2019.09.033.

Guo X, Liu B, Zhang Y, Cheong S, Xu T, Lu F, et al. Decellularized extracellular matrix for organoid and engineered organ culture. J Tissue Eng. 2024;(15):20417314241300386. DOI: 10.1177/20417314241300386.

Leiva MC, Garre E, Gustafsson A, Svanström A, Bogestål Y, Håkansson J, et al. Breast cancer patient-derived scaffolds as a tool to monitor chemotherapy responses in human tumor microenvironments. J Cell Physiol. 2021;236(6):4709-4724.DOI: 10.1002/jcp.30191.

Jin Q, Liu G, Li S, Yuan H, Yun Z, Zhang W, et al. Decellularized breast matrix as bioactive microenvironment for in vitro three-dimensional cancer culture. J Cell Physiol. 2019;234(4):3425-3435.DOI: 10.1002/jcp.26782.

Wishart AL, Conner SJ, Guarin JR, Fatherree JP, Peng Y, McGinn RA, et al. Decellularized extracellular matrix scaffolds identify full-length collagen VI as a driver of breast cancer cell invasion in obesity and metastasis. Sci Adv. 2020;6(43):1-13.DOI: 10.1126/sciadv.abc3175.

Zhu T, Alves SM, Adamo A, Wen X, Corn KC, Shostak A, et al. Mammary tissue-derived extracellular matrix hydrogels reveal the role of irradiation in driving a pro-tumor and immunosuppressive microenvironment. Biomaterials. 2024;308:122531,1-29.DOI: 10.1016/j.biomaterials.2024.122531.

Micek HM, Visetsouk MR, Masters KS, Kreeger PK. Engineering the extracellular matrix to model the evolving tumor microenvironment. iScience. 2020;23(11):101742,1-12.DOI: 10.1016/j.isci.2020.101742.

Kort-Mascort J, Bao G, Elkashty O, Flores-Torres S, Munguia-Lopez JG, Jiang T, et al. Decellularized extracellular matrix composite hydrogel bioinks for the development of 3d bioprinted head and neck in vitro tumor models. ACS Biomater Sci Eng. 2021;7(11):5288-5300.DOI: 10.1021/acsbiomaterials.1c00812.

Romero-López M, Trinh AL, Sobrino A, Hatch MM, Keating MT, Fimbres C, et al. Recapitulating the human tumor microenvironment:colon tumor-derived extracellular matrix promotes angiogenesis and tumor cell growth. Biomaterials. 2017;116:118-129.DOI: 10.1016/j.biomaterials.2016.11.034.

Koh I, Cha J, Park J, Choi J, Kang SG, Kim P. The mode and dynamics of glioblastoma cell invasion into a decellularized tissue-derived extracellular matrix-based three-dimensional tumor model. Sci Rep. 2018;8(1):4608,1=12.DOI: 10.1038/s41598-018-22681-3.

Li W, Hu X, Yang S, Wang S, Zhang C, Wang H, et al. A novel tissue-engineered 3D tumor model for anti-cancer drug discovery. Biofabrication. 2018;11(1):015004,1-35.DOI: 10.1088/1758-5090/aae270.

Lü WD, Zhang L, Wu CL, Liu ZG, Lei GY, Liu J, et al. Development of an acellular tumor extracellular matrix as a three-dimensional scaffold for tumor engineering. PLoS One. 2014;9(7):e103672,1-13.DOI: 10.1371/journal.pone.0103672.

Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71,1-9.DOI: 10.1136/bmj.n71.

Guo S, Yao Y, Tang Y, Xin Z, Wu D, Ni C, et al. Radiation-induced tumor immune microenvironments and potential targets for combination therapy. Signal Transduct Target Ther. 2023;8(1):205,1-22.DOI: 10.1038/s41392-023-01462-z.

Castelló-Cros R, Khan DR, Simons J, Valianou M, Cukierman E. Staged stromal extracellular 3D matrices differentially regulate breast cancer cell responses through PI3K and beta1-integrins. BMC Cancer. 2009;9:94,1-19.DOI: 10.1186/1471-2407-9-94.

Hoshiba T, Tanaka M. Breast cancer cell behaviors on staged tumorigenesis-mimicking matrices derived from tumor cells at various malignant stages. Biochem Biophys Res Commun. 2013;439(2):291-296.

DOI: 10.1016/j.bbrc.2013.08.038.

Aguado BA, Caffe JR, Nanavati D, Rao SS, Bushnell GG, Azarin SM, et al. Extracellular matrix mediators of metastatic cell colonization characterized using scaffold mimics of the pre-metastatic niche. Acta Biomater. 2016;33:13-24.DOI: 10.1016/j.actbio.2016.01.043.

Amens JN, Bahçecioğlu G, Dwyer K, Yue XS, Stack MS, Hilliard TS, et al. Maternal obesity driven changes in collagen linearity of breast extracellular matrix induces invasive mammary epithelial cell phenotype. Biomaterials. 2023;297:122110,1-20.

Wang L, Yang J, Hu X, Wang S, Wang Y, Sun T, et al. A decellularized lung extracellular matrix/chondroitin sulfate/gelatin/chitosan-based 3D culture system shapes breast cancer lung metastasis. Biomater Adv. 2023;152:213500.DOI: 10.1016/j.bioadv.2023.213500.

Weng B, Li M, Zhu W, Peng J, Mao X, Zheng Y, et al. Distinguished biomimetic dECM system facilitates early detection of metastatic breast cancer cells. Bioeng Transl Med. 2023;9(1):e10597,1-19.DOI: 10.1002/btm2.10597.

Tan Q, Xu L, Zhang J, Ning L, Jiang Y, He T, et al. Breast cancer cells interact with tumor-derived extracellular matrix in a molecular subtype-specific manner. Biomater Adv. 2023;146:213301,1-11.DOI: 10.1016/j.bioadv.2023.213301.

Tevlek A. The role of decellularized cell derived extracellular matrix in the establishment and culture of in vitro breast cancer tumor model. Biomed Mater. 2024;19(2).DOI: 10.1088/1748-605X/ad2378.

Pospelov AD, Kutova OM, Efremov YM, Nekrasova AA, Trushina DB, Gefter SD, et al. Breast cancer cell type and biomechanical properties of decellularized mouse organs drives tumor cell colonization. Cells. 2023;12(16):1-26.DOI: 10.3390/cells12162030.

Xiong G, Flynn TJ, Chen J, Trinkle C, Xu R. Development of an ex vivo breast cancer lung colonization model utilizing a decellularized lung matrix. Integr Biol (Camb). 2015;7(12):1518-1525.DOI: 10.1039/c5ib00157a.

Dunne LW, Huang Z, Meng W, Fan X, Zhang N, Zhang Q, et al. Human decellularized adipose tissue scaffold as a model for breast cancer cell growth and drug treatments. Biomaterials. 2014;35(18):4940-4949.DOI: 10.1016/j.biomaterials.2014.03.003.

Liu G, Wang B, Li S, Jin Q, Dai Y. Human breast cancer decellularized scaffolds promote epithelial-to-mesenchymal transitions and stemness of breast cancer cells in vitro. J Cell Physiol. 2019;234(6):9447-9456.DOI: 10.1002/jcp.27630.

Landberg G, Fitzpatrick P, Isakson P, Jonasson E, Karlsson J, Larsson E, et al. Patient-derived scaffolds uncover breast cancer promoting properties of the microenvironment. Biomaterials. 2020;235:119705,1-15.DOI: 10.1016/j.biomaterials.2019.119705.

Ganjibakhsh M, Mehraein F, Koruji M, Aflatoonian R, Farzaneh P. Three-dimensional decellularized amnion membrane scaffold as a novel tool for cancer research;cell behavior, drug resistance and cancer stem cell content. Mater Sci Eng C Mater Biol Appl. 2019;100:330-340.DOI: 10.1016/j.msec.2019.02.090.

Demirkaya D. Development of a hydrogel based prostate tumor model for cancer cell migration studies:Middle East Technical University; 2022:1-83.

Lescarbeau RM, Seib FP, Prewitz M, Werner C, Kaplan DL. In vitro model of metastasis to bone marrow mediates prostate cancer castration resistant growth through paracrine and extracellular matrix factors. PLoS One. 2012;7(8):e40372,1-11.DOI: 10.1371/journal.pone.0040372.

Reichert JC, Quent VM, Burke LJ, Stansfield SH, Clements JA, Hutmacher DW. Mineralized human primary osteoblast matrices as a model system to analyse interactions of prostate cancer cells with the bone microenvironment. Biomaterials. 2010;31(31):7928-7936.DOI: 10.1016/j.biomaterials.2010.06.055.

Lacombe J, Harris AF, Zenhausern R, Karsunsky S, Zenhausern F. Plant-based scaffolds modify cellular response to drug and radiation exposure compared to standard cell culture models. Front Bioeng Biotechnol. 2020;8:932,1-15.DOI: 10.3389/fbioe.2020.00932.

Caley MP, King H, Shah N, Wang K, Rodriguez-Teja M, Gronau JH, et al. Tumor-associated Endo180 requires stromal-derived LOX to promote metastatic prostate cancer cell migration on human ECM surfaces. Clin Exp Metastasis. 2016;33(2):151-165.DOI: 10.1007/s10585-015-9765-7.

Cazzaniga W, Nebuloni M, Longhi E, Locatelli I, Allevi R, Lucianò R, et al. Human prostate tissue-derived extracellular matrix as a model of prostate microenvironment. Eur Urol Focus. 2016;2(4):400-408.DOI: 10.1016/j.euf.2016.02.016.

Kajbafzadeh AM, Jafarnezhad-Ansariha F, Sharifi SHH, Sabetkish S, Parvin M, Tabatabaei S, et al. Decellularization and recellularization of natural, benign prostatic hyperplasia and malignant human prostatic tissues:role of extracellular matrix behavior on development of prostate cancer. Regen Eng Transl Med. 2023;9(1):533-546.DOI: 10.1007/s40883-023-00299-w.

Tamayo-Angorrilla M, López de Andrés J, Jiménez G, Marchal JA. The biomimetic extracellular matrix: a therapeutic tool for breast cancer research. Transl Res. 2022;247:117-136.DOI: 10.1016/j.trsl.2021.11.008.

Lv Y, Wang H, Li G, Zhao B. Three-dimensional decellularized tumor extracellular matrices with different stiffness as bioengineered tumor scaffolds. Bioact Mater. 2021;6(9):2767-2782.DOI: /10.1016/j.bioactmat.2021.02.004.


Refbacks

  • There are currently no refbacks.


Creative Commons LicenseThis work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License which allows users to read, copy, distribute and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited properly.